Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology

Yaobitong capsules reshape and rebalance the gut microbiota and metabolites of arthritic rats: An integrated study of microbiome and fecal metabolomics analysis

(2022) Wei Shi et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Intake of Bifidobacterium lactis Probio-M8 fermented milk protects against alcoholic liver disease

(2022) Qiuwen He et al.   JOURNAL OF DAIRY SCIENCE

Traditional Tibetan Medicine Twenty-Five Wei’er Tea Pills Ameliorate Rheumatoid Arthritis Based on Chemical Crosstalk Between Gut Microbiota and the Host

(2022) Zixuan Li et al.   Frontiers in Pharmacology

Intestinal Barrier and Permeability in Health, Obesity and NAFLD

(2022) Piero Portincasa et al.   Biomedicines

Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis

(2022) Linlin Wang et al.   Biomedicines

Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota

(2022) Junbin Yan et al.   Frontiers in Cellular and Infection Microbiology

Characterising the Intestinal Bacterial and Fungal Microbiome Associated With Different Cytokine Profiles in Two Bifidobacterium strains Pre-Treated Rats With D-Galactosamine-Induced Liver Injury

(2022) Hua Zha et al.   Frontiers in Immunology

Protective Effects of Intestinal Gallic Acid in Neonatal Dairy Calves Against Extended-Spectrum β-lactamase Producing Enteroaggregative Escherichia coli Infection: Modulating Intestinal Homeostasis and Colitis

(2022) Zhiyuan He et al.   Frontiers in Nutrition

Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis

(2021) Wenyi Liang et al.   Frontiers in Pharmacology

Plasma 3-hydroxyisobutyrate (3-HIB) and methylmalonic acid (MMA) are markers of hepatic mitochondrial fatty acid oxidation in male Wistar rats

(2021) Mona Synnøve Bjune et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Nonalcoholic Fatty Liver Disease: A Global Perspective

(2021) Wei-Kei Wong et al.   CLINICAL THERAPEUTICS

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver

(2021) Masayoshi Ko et al.   Disease Models & Mechanisms

Anti-NAFLD effect of defatted walnut powder extract in high fat diet-induced C57BL/6 mice by modulating the gut microbiota

(2021) Shu-meng Ren et al.   JOURNAL OF ETHNOPHARMACOLOGY

Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway

(2021) Chunlin Li et al.   BIOMEDICINE & PHARMACOTHERAPY

Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests

(2021) Mojgan Masoodi et al.   Nature Reviews Gastroenterology & Hepatology

The Effects of Erchen Decoction on Gut Microbiota and Lipid Metabolism Disorders in Zucker Diabetic Fatty Rats

(2021) Tian Zhao et al.   Frontiers in Pharmacology

Protective Effects of Ellagic Acid Against Alcoholic Liver Disease in Mice

(2021) Liang Zhao et al.   Frontiers in Nutrition

Jaboticaba (Myrciaria jaboticaba) powder consumption improves the metabolic profile and regulates gut microbiome composition in high-fat diet-fed mice

(2021) Elaine Soares et al.   BIOMEDICINE & PHARMACOTHERAPY

Hepatoprotective Effect and Potential Mechanism of Aqueous Extract from Phyllanthus emblica on Carbon-Tetrachloride-Induced Liver Fibrosis in Rats

(2021) Kehuan Yin et al.   Evidence-based Complementary and Alternative Medicine

Traditional uses, bioactive composition, pharmacology, and toxicology of Phyllanthus emblica fruits: A comprehensive review

(2021) Rakshandha Saini et al.   JOURNAL OF ETHNOPHARMACOLOGY

Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction

(2021) Shuyu Li et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation

(2021) Linlin Chen et al.   PHYTOMEDICINE

Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model

(2021) Hu Li et al.   Frontiers in Pharmacology

Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia via Inhibiting FXR to Induce CYP7A1

(2021) Lu Xiao-Rong et al.   Frontiers in Pharmacology

The Regulatory Effects of Citrus Peel Powder on Liver Metabolites and Gut Flora in Mice with Non-Alcoholic Fatty Liver Disease (NAFLD)

(2021) Meiyi Hu et al.   Foods

Mechanisms of Fibrosis Development in NASH

(2020) Robert F. Schwabe et al.   GASTROENTEROLOGY

Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?

(2020) Judith Aron-Wisnewsky et al.   GASTROENTEROLOGY

Bifidobacterium affected the correlation between gut microbial composition, SCFA metabolism, and immunity in mice with DNFB-induced atopic dermatitis

(2020) Zhifeng Fang et al.   Food Bioscience

Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice

(2020) Qiong Li et al.   JOURNAL OF ETHNOPHARMACOLOGY

The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non‐Alcoholic Fatty Liver Disease

(2020) Yinhua Ni et al.   MOLECULAR NUTRITION & FOOD RESEARCH

The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health

(2020) Bianca J. Parker et al.   Frontiers in Immunology

Monascus purpureus-fermented common buckwheat protects against dyslipidemia and non-alcoholic fatty liver disease through the regulation of liver metabolome and intestinal microbiome

(2020) Zi-Rui Huang et al.   FOOD RESEARCH INTERNATIONAL

Endogenous metabolite, kynurenic acid, attenuates nonalcoholic fatty liver disease via AMPK/autophagy‐ and AMPK/ORP150‐mediated signaling

(2020) Do Hyeon Pyun et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease

(2019) Ki Tae Suk et al.   Expert Review of Gastroenterology & Hepatology

Dynamic changes of key metabolites during liver fibrosis in rats

(2019) Jiong Yu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice

(2019) David Porras et al.   MOLECULAR NUTRITION & FOOD RESEARCH

A Two-Week Treatment with Plant Extracts Changes Gut Microbiota, Caecum Metabolome, and Markers of Lipid Metabolism in ob/ob Mice

(2019) Amandine Brochot et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease

(2018) Allison Agus et al.   Cell Host & Microbe

The gut microbiota metabolite indole alleviates liver inflammation in mice

(2018) Martin Beaumont et al.   FASEB JOURNAL

Effect of Phyllanthus emblica L. fruit on methionine and choline-deficiency diet-induced nonalcoholic steatohepatitis

(2018) Yu-Tang Tung et al.   JOURNAL OF FOOD AND DRUG ANALYSIS

Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”

(2018) Yan-Lan Fang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Microbial tryptophan catabolites in health and disease

(2018) Henrik M. Roager et al.   Nature Communications

The role of the microbiome in NAFLD and NASH

(2018) Aleksandra A Kolodziejczyk et al.   EMBO Molecular Medicine

Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease

(2017) Feng Shen et al.   Hepatobiliary & Pancreatic Diseases International

Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

(2017) Anna M. Diehl et al.   NEW ENGLAND JOURNAL OF MEDICINE

The hepatoprotective effect of Phyllanthus emblica L. fruit on high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in SD rats

(2017) Cheng-Ze Huang et al.   Food & Function

Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia

(2017) Li Xue et al.   Scientific Reports

Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms

(2016) Bhavesh C. Variya et al.   PHARMACOLOGICAL RESEARCH

Non-alcoholic fatty liver and the gut microbiota

(2016) Stavros Bashiardes et al.   Molecular Metabolism

An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis

(2013) Masahiko Matsumoto et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice

(2012) Tiphaine Le Roy et al.   GUT

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS